JIUDIAN PHARMACEUTICAL: The Phase III clinical trial report for Jiaoqi Pain Relief Gel Patch has been released

JIUDIAN PHARMACEUTICAL announced that the company recently obtained the summary report of the Phase III clinical trial for the Jiao Qi Pain Relief Gel Patch. The results show that the drug is significantly effective in improving pain caused by knee osteoarthritis. The trial group showed significant differences compared to the placebo group in terms of changes in VAS pain scores for the target side knee joint after 2 weeks and 1 week of medication, pain relief effectiveness rate, changes in total WOMAC scores, and total effective rate of Traditional Chinese Medicine syndromes. Additionally, the onset time for pain relief was faster. Furthermore, the trial group occasionally experienced mild adverse reactions such as itching and skin burning sensation, with no serious adverse reactions reported, indicating good safety. The drug is convenient to use and is worthy of clinical promotion. The company will continue to advance the registration application, and it can only be marketed after approval